Northwestern University Clinical and Translational Science Institute (NUCATS)

西北大学临床与转化科学研究所 (NUCATS)

• 批准号: 10434852
• 负责人: Leena Sharma
• 金额: $ 110.86万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-08-12 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10434852
• 关键词: Academia; Appointment; Area; Clinical Sciences; Clinical Trials; Collaborations; Communities; Data; Dissemination and Implementation; Diverse Workforce; Doctor of Philosophy; Future; Genomics; Goals; Government; Grant; Individual; Industry; Institutes; Intervention; Laboratories; Mentors; Outcome Measure; Program Development; Publications; Records; Research; Research Personnel; Research Project Grants; Resource Development; Resources; Science; Testing; Training; Training and Education; Translational Research; Translations; United States Agency for Healthcare Research and Quality; United States National Institutes of Health; Universities; Vocational Guidance; base; career development; design; experience; falls; improved; innovation; peer coaching; programs; success; training opportunity

ABSTRACT: NUCATS began our KL2 program in 2008, along with numerous other programs to support K scholars across our hub. The 25 KL2 scholars who have participated in the program include 11 MDs, 8 MD/PhDs and 7 PhDs, whose research areas span laboratory-based translational discovery, outcome measures testing, genomic translation, clinical trials, and community-level interventions. As of fall 2018, 21 KL2 scholars have completed the program. The progress of the KL2 program at NU has been outstanding. The scholars' publication and grant records are exceptional. Seventy-five percent (15/21) of those who completed the program have received individual or independent NIH, DHHS, or AHRQ grant support, including 3 K08s, 1 K22, 5 K23s, 12 R01s, 2 R03s, 1 R18, 1 R21, and 1 R34 Furthermore, 85% of those who have completed the program received NIH support as a PI or a significant contributor, while 90% have received some form of NIH or non-NIH grant support. Subsequent to their appointment periods, our scholars have received a combined total of over $45 million in direct research grants as PIs. Approximately 704 publications (mean 34), as author or co-author, have been attributed to the 21 scholars who have completed the program, after they joined the KL2 program. These data document a strong and sustained impact of the NUCATS KL2 Career Development Program on the CTS community. Closely aligned with the overall goals of NUCATS, we will now build on our outstanding legacy and enhance our impact through three initiatives, by: refining our proven programs, which are based on robust mentoring teams and designed around the educational needs of individual scholars to provide them with optimal, personalized career development opportunities; providing career development resources including formal courses, peer mentoring and systematic career guidance to scholars across disparate areas of expertise; and integrating collaboration, training and resources for scholars, including opportunities for training in team science and community implementation and dissemination, for research experiences in academia, government and industry, and for interactions with other local CTSAs.

摘要：NUCATS在2008年开始了我们的KL2计划，以及许多其他支持K 学者们在我们的中心。参加该计划的25名KL2学者包括11名医学博士，8名 博士/博士和7名博士，他们的研究领域涵盖基于实验室的翻译发现，成果 衡量检测、基因组翻译、临床试验和社区层面的干预。截至2018年秋季，21 KL2学者已经完成了该计划。NU的KL2方案取得了显著的进展。 这些学者的出版和资助记录是例外的。75%(15/21)的人 已完成该计划的人获得了个人或独立的NIH、DHHS或AHRQ赠款支持，包括 3个K08、1个K22、5个K23、12个R01、2个R03、1个R18、1个R21和1个R34 完成该计划后，作为私人投资或重要贡献者，NIH获得了支持，而90%的人获得了 某种形式的NIH或非NIH赠款支持。在他们的委任期之后，我们的学者们 作为私人投资机构，获得的直接研究补助金总额超过4500万美元。大约704种出版物 (平均34人)，作为作者或合著者，被归因于完成该计划的21名学者， 在他们加入KL2计划之后。这些数据证明了NUCATS KL2的强大和持续的影响 关于CTS社区的职业发展计划。与NUCATS的总体目标紧密结合，我们 现在将在我们杰出遗产的基础上，通过以下三项举措增强我们的影响力：完善我们的 成熟的计划，以强大的指导团队为基础，围绕以下教育需求进行设计 个别学者为他们提供最佳的、个性化的职业发展机会；提供 职业发展资源，包括正规课程、同伴指导和系统的职业指导，以 跨不同专业领域的学者；整合学者的合作、培训和资源， 包括在团队科学以及社区实施和传播方面的培训机会 在学术界、政府和工业界的研究经验，以及与其他地方CTSA的互动。